Table 1 Baseline characteristics of the study population.
From: Pulmonary artery blood flow dynamics in chronic thromboembolic pulmonary hypertension
|  | All CTEPH (n = 10) | Central (n = 5) | Peripheral (n = 5) | p-value |
|---|---|---|---|---|
Age, years | 66.8 ± 9.3 | 65.0 ± 9.3 | 68.6 ± 8.3 | 0.39 |
Female, n (%) | 8 (80) | 3 (60) | 5 (100) | 0.11 |
WHO-FC I/II/III/IV, n | 0/1/6/3 | 0/0/3/2 | 0/1/3/1 | 0.51 |
6MWD, m | 401.7 ± 54.9 | 369.0 ± 53.1 | 442.5 ± 16.3 | 0.02 |
BNP, pg/mL | 207.5 (93.2–252.0) | 209.0 (157.0–220.0) | 206.0 (23.8–252.0) | 0.75 |
Medication, n (%) | ||||
 sGC stimulator | 1 (10) | 1 (20) | 0 (0) | 0.29 |
 Diuretics | 7 (70) | 5 (100) | 2 (40) | 0.03 |
Hemodynamics | ||||
 RAP, mmHg | 6.7 ± 5.1 | 2.4 ± 1.5 | 11.0 ± 3.0 |  < 0.01 |
 PAWP, mmHg | 9.0 ± 4.5 | 5.8 ± 2.7 | 12.2 ± 3.7 | 0.01 |
 sPAP, mmHg | 79.3 ± 18.3 | 86.2 ± 21.3 | 72.4 ± 13.2 | 0.29 |
 dPAP, mmHg | 26.5 ± 7.0 | 26.2 ± 8.5 | 26.8 ± 6.1 | 0.67 |
 mPAP, mmHg | 44.5 ± 9.5 | 46.6 ± 12.1 | 42.4 ± 6.7 | 0.46 |
 CO, L/min | 3.2 ± 0.7 | 3.0 ± 0.4 | 3.5 ± 0.8 | 0.17 |
 CI, L/min/m2 | 2.1 ± 0.4 | 2.1 ± 0.3 | 2.2 ± 0.5 | 0.75 |
 PVR, WU | 12.2 ± 4.6 | 14.3 ± 5.7 | 10.0 ± 2.0 | 0.20 |
